Phelan-McDermid syndrome may be more common than previously believed

	Autism
	The latest autism news from News Medical

	Phelan-McDermid syndrome may be more common than previously believed New research, led by scientists from the Seaver Autism Center for Research and Treatment at Mount Sinai and published June 28 in Autism Research, has estimated that Phelan-McDermid syndrome (PMS) affects approximately 1 in 7,300 people, making it dramatically more common than previous estimates suggested.

	Brain signals explain speech communication differences in autistic children Why do some children with autism communicate more easily than others, even when they hear the same words?

			GLP-1 receptor activation linked to lower depression and bipolar disorder odds Genetic analyses linked BMI-related GLP-1 receptor activation to better mental well-being and lower odds of major depressive disorder and bipolar disorder. The findings do not prove that GLP-1 receptor agonist drugs treat psychiatric conditions, and randomized clinical trials are still needed.

			New study reveals why autistic teens struggle with sounds of unfamiliar voices Just like other teenagers, many teens on the autism spectrum are itching to exercise their social muscles. They hope for new friends, fun with people who share their interests, maybe even a romantic relationship.

			ADHD and autism traits share a common developmental spectrum Research identifies a neurodevelopmental spectrum for ADHD and autism, emphasizing genetic links and their impact on cognitive and educational outcomes.

	Early detection of congenital cerebral ventriculomegaly can help prevent developmental disabilities Early detection and treatment of congenital cerebral ventriculomegaly (CCV)-when a fetus's fluid-filled brain ventricles swell due to a condition called hydrocephalus-can help clinicians prevent developmental or neurological disabilities in affected infants.

	Experimental gene therapy reverses fragile X symptoms in mice A gene therapy designed to replace the missing protein that causes fragile X syndrome restored several disease-relevant traits in a mouse model, according to a new study published in Gene Therapy.

	Prenatal use of certain medications can harm developing fetal brain A review article by a University of Nebraska Medical Center/Child Health Research Institute research team underscores and describes how altering fundamental brain development processes can be detrimental for the developing baby.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026